Telogen Effluvium in SARS-CoV-2 Infection: Histological Aspects
March 2023
in “
Journal of the European Academy of Dermatology and Venereology
”
TLDR COVID-19 can cause a temporary hair loss condition.
Research cited in this study
6 / 6 results
research The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series
Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.
research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management
COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.
research Telogen Effluvium: A Review of the Science and Current Obstacles
The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.
research Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.
research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study
COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.
research Telogen Effluvium: A Review
Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.